Alveolar proteinosis – disease with unpredictable evolution (series of clinical cases)

1Borie R, Danel C, Debray M-P, Taille C, Dombret M-C, Aubier M, et al. Pulmonary alveolar proteinosis. The European Respiratory Review. 2011;20(120): 98–107.BorieRDanelCDebrayM-PTailleCDombretM-CAubierMPulmonary alveolar proteinosisThe European Respiratory Review2011201209810710.1007/978-1-4471-2401-6_18Search in Google Scholar

2Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. The New England Journal of Medicine. 1958:258(23): 1123–1142.RosenSHCastlemanBLiebowAAPulmonary alveolar proteinosisThe New England Journal of Medicine1958258231123114210.1056/NEJM195806052582301Search in Google Scholar

3Inoue Y, Trapnell BC, Tazawa R, Arai T, Takada T, Hizawa N, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. American Journal of Respiratory and Critical Care Medicine. 2008;177: 752–762.InoueYTrapnellBCTazawaRAraiTTakadaTHizawaNCharacteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in JapanAmerican Journal of Respiratory and Critical Care Medicine200817775276210.1164/rccm.200708-1271OCSearch in Google Scholar

4Bonella F, Bauer PC, Griese M, Ohshimo S, Guzman J, Costabel U. Pulmonary alveolar proteinosis: new insights from a single-center cohort of 70 patients. Respiratory Medicine. 2011:105(12): 1908–1916.BonellaFBauerPCGrieseMOhshimoSGuzmanJCostabelUPulmonary alveolar proteinosis: new insights from a single-center cohort of 70 patientsRespiratory Medicine2011105121908191610.1016/j.rmed.2011.08.018Search in Google Scholar

5Whitsett JA, Wert SE, Weaver TE. Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annual Review of Medicine. 2010;61: 105–119.WhitsettJAWertSEWeaverTEAlveolar surfactant homeostasis and the pathogenesis of pulmonary diseaseAnnual Review of Medicine20106110511910.1146/annurev.med.60.041807.123500Search in Google Scholar

6Shibata Y, Berclaz PY, Chroneos ZC, Yoshida M, Whitsett JA, Trapnell BC. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity. 2001;15: 557–567.ShibataYBerclazPYChroneosZCYoshidaMWhitsettJATrapnellBCGM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1Immunity20011555756710.1016/S1074-7613(01)00218-7Search in Google Scholar

7Kitamura T, Tanaka N, Watanabe J, Uchida, Kanegasaki S, Yamada Y, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. The Journal of Experimental Medicine. 1999;190: 875–880.KitamuraTTanakaNWatanabeJUchidaKanegasakiSYamadaYIdiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factorThe Journal of Experimental Medicine199919087588010.1084/jem.190.6.875219562710499925Search in Google Scholar

8Kitamura T, Uchida K, Tanaka N, Tsuchiya T, Watanabe J, Yamada Y, et al. Serological diagnosis of idiopathic pulmonary alveolar proteinosis. American Journal of Respiratory and Critical Care Medicine. 2000;162:658–662.KitamuraTUchidaKTanakaNTsuchiyaTWatanabeJYamadaYSerological diagnosis of idiopathic pulmonary alveolar proteinosisAmerican Journal of Respiratory and Critical Care Medicine200016265866210.1164/ajrccm.162.2.991003210934102Search in Google Scholar

9Costabel U, Guzman J. Pulmonary alveolar proteinosis: a new autoimmune disease. Sarcoidosis Vasculitis and Diffuse Lung Disease. 2005;22(Suppl 1): 67S–73S.CostabelUGuzmanJPulmonary alveolar proteinosis: a new autoimmune diseaseSarcoidosis Vasculitis and Diffuse Lung Disease200522Suppl 167S73SSearch in Google Scholar

10Dirksen U, Hattenhorst U, Schneider P, Schroten H, Göbel U, Böcking A, et al. Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure. Blood. 1998;92: 1097–1103.DirksenUHattenhorstUSchneiderPSchrotenHGöbelUBöckingADefective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failureBlood19989210971103Search in Google Scholar

11Ishii H, Seymour JF, Tazawa R, Inoue Y, Uchida N, Nishida A, et al. Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan. BMC Pulmonary Medicine. 2014;14: 37.IshiiHSeymourJFTazawaRInoueYUchidaNNishidaASecondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in JapanBMC Pulmonary Medicine2014143710.1186/1471-2466-14-37394619024597668Search in Google Scholar

12Ishii H, Tazawa R, Kaneko C, Saraya T, Inoue Y, Hamano E, et al. Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan. European Respiratory Journal. 2011;37(2): 465–468.IshiiHTazawaRKanekoCSarayaTInoueYHamanoEClinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in JapanEuropean Respiratory Journal201137246546810.1183/09031936.0009291021282812Search in Google Scholar

13Heppleston AG, Wright NA, Stewart JA. Experimental alveolar lipo-proteinosis following the inhalation of silica. The Journal of Pathology. 1970;101(4): 293–307.HepplestonAGWrightNAStewartJAExperimental alveolar lipo-proteinosis following the inhalation of silicaThe Journal of Pathology1970101429330710.1002/path.17110104024323445Search in Google Scholar

14Cummings KJ, Donat WE, Ettensohn DB, Roggli VL, Ingram P, Kreiss K. Pulmonary alveolar proteinosis in workers at an indium processing facility. American Journal of Respiratory and Critical Care Medicine. 2010;181(5): 458–464.CummingsKJDonatWEEttensohnDBRoggliVLIngramPKreissKPulmonary alveolar proteinosis in workers at an indium processing facilityAmerican Journal of Respiratory and Critical Care Medicine2010181545846410.1164/rccm.200907-1022CR315908620019344Search in Google Scholar

15Suzuki T, Sakagami T, Young LR, Carey BC, Wood RE, Luisetti M, et al. Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy. American Journal of Respiratory and Critical Care Medicine. 2010;182: 1292–1304.SuzukiTSakagamiTYoungLRCareyBCWoodRELuisettiMHereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapyAmerican Journal of Respiratory and Critical Care Medicine20101821292130410.1164/rccm.201002-0271OC300126620622029Search in Google Scholar

16Suzuki T, Sakagami T, Rubin BK, Nogee LM, Wood RE, Zimmerman SL, et al. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. The Journal of Experimental Medicine. 2008;205(12): 2703–2710.SuzukiTSakagamiTRubinBKNogeeLMWoodREZimmermanSLFamilial pulmonary alveolar proteinosis caused by mutations in CSF2RAThe Journal of Experimental Medicine2008205122703271010.1084/jem.20080990258584518955570Search in Google Scholar

17Tredano M, Griese M, Brasch F, Schumacher S, de Blic J, Marque S, et al. Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease. American Journal of Medical Genetics Part A. 2004;126(1): 18–26.TredanoMGrieseMBraschFSchumacherSde BlicJMarqueSMutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung diseaseAmerican Journal of Medical Genetics Part A20041261182610.1002/ajmg.a.2067015039969Search in Google Scholar

18Shah PL, Hansell D, Lawson PR, Reid KB, Morgan C. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax. 2000;55(1): 67–77.ShahPLHansellDLawsonPRReidKBMorganCPulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesisThorax2000551677710.1136/thorax.55.1.67174559510607805Search in Google Scholar

19Goldstein LS, Kavuru MS, Curtis-McCarthy P, Christie HA, Farver C, Stoller JK. Pulmonary alveolar proteinosis: clinical features and outcomes. Chest. 1998;114(5): 1357–1362.GoldsteinLSKavuruMSCurtis-McCarthyPChristieHAFarverCStollerJKPulmonary alveolar proteinosis: clinical features and outcomesChest199811451357136210.1378/chest.114.5.13579824014Search in Google Scholar

20Lee KN, Levin DL, Webb WR, Chen D, Storto ML, Golden JA. Pulmonary alveolar proteinosis: high-resolution CT, chest radiographic, and functional correlations. Chest. 1997;111(4): 989–995.LeeKNLevinDLWebbWRChenDStortoMLGoldenJAPulmonary alveolar proteinosis: high-resolution CT, chest radiographic, and functional correlationsChest1997111498999510.1378/chest.111.4.9899106579Search in Google Scholar

21Holbert JM, Costello P, Li W, Hoffman RM, Rogers RM. CT features of pulmonary alveolar proteinosis. American Journal of Roentgenology. 2001;176: 1287–1294.HolbertJMCostelloPLiWHoffmanRMRogersRMCT features of pulmonary alveolar proteinosisAmerican Journal of Roentgenology20011761287129410.2214/ajr.176.5.176128711312196Search in Google Scholar

22Johkoh T, Itoh H, Muller NL, Ichikado K, Nakamura H, Ikezoe J, et al. Crazy-paving appearance at thin-section CT: spectrum of disease and pathologic findings. Radiology. 1999;211: 155–160.JohkohTItohHMullerNLIchikadoKNakamuraHIkezoeJCrazy-paving appearance at thin-section CT: spectrum of disease and pathologic findingsRadiology199921115516010.1148/radiology.211.1.r99ap1015510189465Search in Google Scholar

23Ishii H, Trapnell BC, Tazawa R, Inoue Y, Akira M, Kogure Y, et al. Comparative study of high-resolution CT findings between auto-immune and secondary pulmonary alveolar proteinosis. Chest. 2009;136(5): 1348–1355.IshiiHTrapnellBCTazawaRInoueYAkiraMKogureYComparative study of high-resolution CT findings between auto-immune and secondary pulmonary alveolar proteinosisChest200913651348135510.1378/chest.09-0097Search in Google Scholar

24Rossi SE, Erasmus JJ, Volpacchio M, Franquet T, Castiglioni T, McAdams HP. “Crazy-paving” pattern at thin-section CT of the lungs: radiologic-pathologic overview. Radiographics. 2003;23(6): 1509–1519.RossiSEErasmusJJVolpacchioMFranquetTCastiglioniTMcAdamsHP“Crazy-paving” pattern at thin-section CT of the lungs: radiologic-pathologic overviewRadiographics20032361509151910.1148/rg.236035101Search in Google Scholar

25Costabel U, Guzman J, Bonella F, Oshimo S. Bronchoalveolar lavage in other interstitial lung diseases. Seminars in Respiratory and Critical Care Medicine. 2007;28(5): 514–524.CostabelUGuzmanJBonellaFOshimoSBronchoalveolar lavage in other interstitial lung diseasesSeminars in Respiratory and Critical Care Medicine200728551452410.1055/s-2007-991525Search in Google Scholar

26Milleron BJ, Costabel U, Teschler H, Ziesche R, Cadranel JL, Matthys H, et al. Bronchoalveolar lavage cell data in alveolar proteinosis. American Review of Respiratory Disease. 1991;144: 1330–1332.MilleronBJCostabelUTeschlerHZiescheRCadranelJLMatthysHBronchoalveolar lavage cell data in alveolar proteinosisAmerican Review of Respiratory Disease19911441330133210.1164/ajrccm/144.6.1330Search in Google Scholar

27Delaval P, Brinchault G, Corre R, Jouneau S, Meunier C, Briens E. Lipoproteinose alveolaire pulmonaire [Pulmonary alveolar phospholipoproteinosis]. Revue de Pneumologie Clinique. 2005;61: 186–192.DelavalPBrinchaultGCorreRJouneauSMeunierCBriensELipoproteinose alveolaire pulmonaire [Pulmonary alveolar phospholipoproteinosis]Revue de Pneumologie Clinique20056118619210.1016/S0761-8417(05)84811-4Search in Google Scholar

28Bonfield TL, Russell D, Burgess S, Malur A, Kavuru MS, Thomassen MJ. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. American Journal of Respiratory Cell and Molecular Biology. 2002;27(4): 481–486.BonfieldTLRussellDBurgessSMalurAKavuruMSThomassenMJAutoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosisAmerican Journal of Respiratory Cell and Molecular Biology200227448148610.1165/rcmb.2002-0023OC12356582Search in Google Scholar

29Uchida K, Nakata K, Trapnell BC, Terakawa T, Hamano E, Mikami A, et al. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood. 2004;103(3):1089–1098.UchidaKNakataKTrapnellBCTerakawaTHamanoEMikamiAHigh-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosisBlood200410331089109810.1182/blood-2003-05-156514512323Search in Google Scholar

30Uchida K, Nakata K, Suzuki T, Luisetti M, Watanabe M, Koch DE, et al. Granulocyte/macrophage colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy individuals. Blood. 2009;113: 2547–2556.UchidaKNakataKSuzukiTLuisettiMWatanabeMKochDEGranulocyte/macrophage colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy individualsBlood20091132547255610.1182/blood-2008-05-155689Search in Google Scholar

31Sergeeva A, Ono Y, Rios R, Molldrem JJ. High titer auto-antibodies to GM-CSF in patients with AML, CML and MDS are associated with active disease. Leukemia. 2008:22(4): 783–790.SergeevaAOnoYRiosRMolldremJJHigh titer auto-antibodies to GM-CSF in patients with AML, CML and MDS are associated with active diseaseLeukemia200822478379010.1038/sj.leu.2405104340338118216869Search in Google Scholar

32Ishikawa N, Hattori N, Yokoyama A, Kohno N. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases. Respiratory Investigation. 2012;50(1): 3–13.IshikawaNHattoriNYokoyamaAKohnoNUtility of KL-6/MUC1 in the clinical management of interstitial lung diseasesRespiratory Investigation201250131310.1016/j.resinv.2012.02.00122554854Search in Google Scholar

33Bonella F, Campo I. Pulmonary alveolar proteinosis. Pneumologia. 2014;144: 147–155.BonellaFCampoIPulmonary alveolar proteinosisPneumologia2014144147155Search in Google Scholar

34Leth S, Bendstrup E, Vestergaard H, Hilberg O. Autoimmune pulmonary alveolar proteinosis: treatment options in year 2013. Respirology 2013;18(1): 82–91.LethSBendstrupEVestergaardHHilbergOAutoimmune pulmonary alveolar proteinosis: treatment options in year 2013Respirology2013181829110.1111/j.1440-1843.2012.02274.x23036113Search in Google Scholar

35Luisetti M. Call for an international survey on therapeutic lavage for pulmonary alveolar proteinosis. European Respiratory Journal. 2012;39(4): 1049.LuisettiMCall for an international survey on therapeutic lavage for pulmonary alveolar proteinosisEuropean Respiratory Journal2012394104910.1183/09031936.0022631122467731Search in Google Scholar

36Ramirez J, Schultz RB, Dutton RE. Pulmonary alveolar proteinosis: a new technique and rationale for treatment. Archives of Internal Medicine. 1963;112: 419–431.RamirezJSchultzRBDuttonREPulmonary alveolar proteinosis: a new technique and rationale for treatmentArchives of Internal Medicine196311241943110.1001/archinte.1963.0386003017302114045290Search in Google Scholar

37Seymour JF, Presneill JJ, Schoch OD, Downie GH, Moore PE, Doyle IR, et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. American Journal of Respiratory and Critical Care Medicine. 2001;163(2): 524–531.SeymourJFPresneillJJSchochODDownieGHMoorePEDoyleIRTherapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosisAmerican Journal of Respiratory and Critical Care Medicine2001163252453110.1164/ajrccm.163.2.200314611179134Search in Google Scholar

38Venkateshiah SB, Yan TD, Bonfield TL, Thomassen MJ, Meziane M, Czich C, et al. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest. 2006;130(1): 227–223.VenkateshiahSBYanTDBonfieldTLThomassenMJMezianeMCzichCAn open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosisChest2006130122722310.1378/chest.130.1.22716840407Search in Google Scholar

39Wylam ME, Ten R, Prakash UB, Nadrous HF, Clawson ML, Anderson PM. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis. European Respiratory Journal. 2006;27(3): 585–593.WylamMETenRPrakashUBNadrousHFClawsonMLAndersonPMAerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosisEuropean Respiratory Journal200627358559310.1183/09031936.06.0005830516507860Search in Google Scholar

40Tazawa R, Trapnell BC, Inoue Y, Arai T, Takada T, Nasuhara Y, et al. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. American Journal of Respiratory and Critical Care Medicine. 2010;181(12): 1345–1354.TazawaRTrapnellBCInoueYAraiTTakadaTNasuharaYInhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosisAmerican Journal of Respiratory and Critical Care Medicine2010181121345135410.1164/rccm.200906-0978OC289441020167854Search in Google Scholar

41Tanner LM, Kurko J, Tringham M, Aho H, Mykkänen J, Näntö-Salonen K, et al. Inhaled sargramostim induces resolution of pulmonary alveolar proteinosis in lysinuric protein intolerance. JIMD Reports. 2017;34: 97–104.TannerLMKurkoJTringhamMAhoHMykkänenJNäntö-SalonenKInhaled sargramostim induces resolution of pulmonary alveolar proteinosis in lysinuric protein intoleranceJIMD Reports2017349710410.1007/8904_2016_15550954127783330Search in Google Scholar

42Onkouchi S, Akasara K, Ichiwata T, Hisata S, Iijima H, Takada T, et al. Sequential granulocyte-macrophage-colony-stimulating factor after whole lung lavage for pulmonary alveolar proteinosis for pulmonary alveolar proteinosis. A report of five intractable cases. Annals of the American Thoracic Society. 2017;14: 1298.OnkouchiSAkasaraKIchiwataTHisataSIijimaHTakadaTSequential granulocyte-macrophage-colony-stimulating factor after whole lung lavage for pulmonary alveolar proteinosis for pulmonary alveolar proteinosis. A report of five intractable casesAnnals of the American Thoracic Society201714129810.1513/AnnalsATS.201611-892BC28421817Search in Google Scholar

43Tazawa R, Ueda T, Abe M, Tatsumi K, Eda R, Kondoh S, et al. Inhaled GM-CSF for Pulmonary Alveolar Proteinosis. The New England Jorunal of Medicine. 2019;381(10): 923–932.TazawaRUedaTAbeMTatsumiKEdaRKondohSInhaled GM-CSF for Pulmonary Alveolar ProteinosisThe New England Jorunal of Medicine20193811092393210.1056/NEJMoa181621631483963Search in Google Scholar

44Kavuru MS, Bonfield TL, Thomassen MJ. Plasmapheresis, GM-CSF, and alveolar proteinosis. American Journal of Respiratory and Critical Care Medicine. 2003;167(7): 1036–1037.KavuruMSBonfieldTLThomassenMJPlasmapheresis, GM-CSF, and alveolar proteinosisAmerican Journal of Respiratory and Critical Care Medicine200316771036103710.1164/ajrccm.167.7.95012663343Search in Google Scholar

45Luisetti M, Rodi G, Perotti C, Campo I, Mariani F, Pozzi E, et al. Plasmapheresis for treatment of pulmonary alveolar proteinosis. European Respiratory Journal. 2009;33(5): 1220–1222.LuisettiMRodiGPerottiCCampoIMarianiFPozziEPlasmapheresis for treatment of pulmonary alveolar proteinosisEuropean Respiratory Journal20093351220122210.1183/09031936.0009750819407056Search in Google Scholar

46Kavuru MS, Malur A, Marshall I, Barna BP, Meziane M, Huizar I, et al. An open-label trial of rituximab therapy in pulmonary alveolar proteinosis. European Respiratory Journal. 2011;38(6): 1361–1367.KavuruMSMalurAMarshallIBarnaBPMezianeMHuizarIAn open-label trial of rituximab therapy in pulmonary alveolar proteinosisEuropean Respiratory Journal20113861361136710.1183/09031936.00197710387472521478218Search in Google Scholar

47Sovez B, Borie R, Menard C, Cadranel J, Chavez L, Cottin V, et al. Rituximab for auto-immune alveolar proteinosis, a real life cohort. Respiratory Research. 2018;19: 74.SovezBBorieRMenardCCadranelJChavezLCottinVRituximab for auto-immune alveolar proteinosis, a real life cohortRespiratory Research2018197410.1186/s12931-018-0780-5591890129695229Search in Google Scholar

48Stoica R, Macri A, Cordos I, Bolca C. Whole lung lavage for pulmonary alveolar proteinosis after surgery for spontaneous pneumothorax. Journal of Medicine and Life. 2012;5(3): 311–315.StoicaRMacriACordosIBolcaCWhole lung lavage for pulmonary alveolar proteinosis after surgery for spontaneous pneumothoraxJournal of Medicine and Life201253311315Search in Google Scholar